Psyence Biomedical Ltd.
PBM
$5.21
-$0.445-7.88%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 1.01M | -22.79M | -46.59M | -48.88M | -51.16M |
| Total Depreciation and Amortization | 4.20K | 3.10K | 2.00K | 1.10K | 200.00 |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -4.36M | 20.20M | 44.76M | 47.07M | 49.39M |
| Change in Net Operating Assets | -386.20K | -713.30K | -1.04M | -1.11M | -1.17M |
| Cash from Operations | -3.73M | -3.30M | -2.87M | -2.91M | -2.95M |
| Capital Expenditure | -9.80K | -11.00K | -12.20K | -9.00K | -5.80K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -6.40K | -3.20K | -- | -- | -- |
| Cash from Investing | -16.20K | -14.20K | -12.20K | -9.00K | -5.80K |
| Total Debt Issued | 1.00M | 1.89M | 2.79M | 2.64M | 2.50M |
| Total Debt Repaid | -- | -75.00K | -150.00K | -150.00K | -150.00K |
| Issuance of Common Stock | 1.74M | 1.73M | 1.72M | 860.80K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 6.41M | 3.13M | -144.40K | -72.20K | 0.00 |
| Cash from Financing | 9.15M | 6.68M | 4.21M | 3.28M | 2.35M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5.40M | 3.36M | 1.33M | 363.10K | -601.00K |